CTOs on the Move

Capcium

www.capcium.com

 
Capcium is a value-add pharmaceutical grade manufacturer of softgel capsules and other novel delivery technologies that was born from a strong desire to transform the cannabis, pharmaceutical, nutraceutical, over the counter (OTC) and cosmetics industries by setting new standards in the development and manufacturing of finished consumer products.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.capcium.com
  • 1675 Rte Transcanadienne Suite 135
    Dorval, QC CAN H9P 1J1
  • Phone: 514.339.5986

Executives

Name Title Contact Details

Similar Companies

West Hill Gastroenterology

West Hill Gastroenterology is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ferring Pharmaceuticals

Ferring Pharmaceuticals, Inc. is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Recovery Systems

Find a rehab center to treat your drug or alcohol addiction, eating disorder, or mental illness. Connect with us and get help for your addiction.

Exeltis

We create solutions for Women´s Health and other priority such as Respiratory, Dermatology and Endocrinology. Excellence and innovation.

Cerebral

At Cerebral, we`re on a mission to democratize access to high-quality mental health care. We believe that everyone everywhere deserves to get the care they need, and are striving to make care convenient and accessible, while tackling the stigmas that surround mental illness. Since launching in January 2020, we have gone from a team of 5 to over 4,000 across the United States. With support from investors like SoftBank, Silver Lake, Access Industries, Bill Ackman, WestCap, and others, and impactful leaders like you, we`ll continue to democratize mental health care and double down on clinical quality and deliver exceptional patient outcomes for years to come. With a heavy focus on clinical quality and safety in all that we do, we`ve accomplished excellent patient outcomes: • 82% of patients report an improvement in their anxiety symptoms after using Cerebral. • 75% of patients who report improvement in their depression see improvement within 60 days. • 50% of patients who initially report suicidal ideation no longer harbor suicidal thoughts after treatment with Cerebral. This is just the beginning for Cerebral, and we won`t stop building, growing, and iterating until everyone, everywhere can access high-quality evidence-based mental health care without high costs and/or long wait times. We`re looking for mission-driven leaders who share these values, and we need your help as we transform access to high-quality mental health care in the United States and beyond.